Form 8-K - Current report:
SEC Accession No. 0001104659-24-117204
Filing Date
2024-11-13
Accepted
2024-11-13 07:00:14
Documents
15
Period of Report
2024-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428268d1_8k.htm   iXBRL 8-K 31310
2 EXHIBIT 99.1 tm2428268d1_ex99-1.htm EX-99.1 28195
6 GRAPHIC tm2428268d1_ex99-1img001.jpg GRAPHIC 3746
  Complete submission text file 0001104659-24-117204.txt   247542

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20241108.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20241108_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20241108_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428268d1_8k_htm.xml XML 3685
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 241451112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)